These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Implementation of an experimental isolated lung perfusion model on surgically resected human lobes. Slama A; Raber C; Hedderich C; Stockhammer P; Hegedüs B; Koch A; Theegarten D; Ploenes T; Aigner C Sci Rep; 2019 Aug; 9(1):12193. PubMed ID: 31434960 [TBL] [Abstract][Full Text] [Related]
65. In vitro circuit stability of 5-fluorouracil and oxaliplatin in support of hyperthermic isolated hepatic perfusion. Colville H; Dzadony R; Kemp R; Stewart S; Zeh HJ; Bartlett DL; Holleran J; Schombert K; Kosovec JE; Egorin MJ; Beumer JH J Extra Corpor Technol; 2010 Mar; 42(1):75-9. PubMed ID: 20437796 [TBL] [Abstract][Full Text] [Related]
66. Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site. Mürdter TE; Sperker B; Kivistö KT; McClellan M; Fritz P; Friedel G; Linder A; Bosslet K; Toomes H; Dierkesmann R; Kroemer HK Cancer Res; 1997 Jun; 57(12):2440-5. PubMed ID: 9192823 [TBL] [Abstract][Full Text] [Related]
67. The ex-vivo isolated, perfused human lung model: description and potential applications. Linder A; Friedel G; Fritz P; Kivistö KT; McClellan M; Toomes H Thorac Cardiovasc Surg; 1996 Jun; 44(3):140-6. PubMed ID: 8858797 [TBL] [Abstract][Full Text] [Related]
68. Dose optimization of a doxorubicin prodrug (HMR 1826) in isolated perfused human lungs: low tumor pH promotes prodrug activation by beta-glucuronidase. Mürdter TE; Friedel G; Backman JT; McClellan M; Schick M; Gerken M; Bosslet K; Fritz P; Toomes H; Kroemer HK; Sperker B J Pharmacol Exp Ther; 2002 Apr; 301(1):223-8. PubMed ID: 11907177 [TBL] [Abstract][Full Text] [Related]
69. Variability of cyclophosphamide uptake into human bronchial carcinoma: consequences for local bioactivation. Bohnenstengel F; Friedel G; Ritter CA; McClellan M; Fritz P; Eichelbaum M; Linder A; Toomes H; Dierkesmann R; Kroemer HK Cancer Chemother Pharmacol; 2000; 45(1):63-8. PubMed ID: 10647504 [TBL] [Abstract][Full Text] [Related]
70. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer. Roy P; Waxman DJ Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390 [TBL] [Abstract][Full Text] [Related]
71. [Pharmacokinetics of cyclophosphamide, adriamycin and adriamycin prodrug (HMR 1928) using an ex vivo isolated perfused human lung model (IHLP)]. Mürdter TE; Linder A; Friedel G; McClellan M; Bohnenstengel F; Sperker B; Kroemer HK; Toomes H; Freitag L; Fritz P Pneumologie; 2000 Nov; 54(11):494-8. PubMed ID: 11132546 [TBL] [Abstract][Full Text] [Related]
72. Antitumour prodrug development using cytochrome P450 (CYP) mediated activation. Patterson LH; McKeown SR; Robson T; Gallagher R; Raleigh SM; Orr S Anticancer Drug Des; 1999 Dec; 14(6):473-86. PubMed ID: 10834269 [TBL] [Abstract][Full Text] [Related]